Table 3 Multivariate analysis of prognostic factors for disease-free survival in endometrial cancer
From: Preoperative serum CA125: a useful marker for surgical management of endometrial cancer
Factor | No of patients | P value | HR | 95.0% CI for HR | |
|---|---|---|---|---|---|
lower | upper | ||||
FIGO stage | Â | Â | Â | Â | Â |
 I | 769 | 0.01 | 1 |  |  |
 II | 85 | 0.15 | 1.40 | 0.88 | 2.20 |
 III | 116 | 0.85 | 1.04 | 0.69 | 1.56 |
 IV | 25 | 0.00 | 2.34 | 1.38 | 3.97 |
Histology grade | Â | Â | Â | Â | Â |
 1 | 495 | 0.00 | 1 |  |  |
 2 | 367 | 0.16 | 1.28 | 0.91 | 1.81 |
 3 | 133 | 0.00 | 2.46 | 1.78 | 3.42 |
Positive peritoneal cytology | Â | Â | Â | Â | Â |
 No | 964 |  | 1 |  |  |
 yes | 31 | 0.00 | 3.24 | 1.89 | 5.32 |
Preoperative serum CA125 | Â | Â | Â | Â | Â |
 ≤25U/mL | 645 | 0.00 | 1 |  |  |
 25-30 U/mL | 65 | 0.00 | 2.86 | 1.71 | 4.78 |
 30-45 U/mL | 109 | 0.06 | 1.54 | 0.98 | 2.41 |
 >45 U/mL | 176 | 0.00 | 2.41 | 1.69 | 3.46 |